Okura Industrial Co., Ltd.

4221.T
Specialty Chemicals
2026/02/16 Updated
Market Cap: $367.9M (¥56.3B)
Stock Price: $32.57 (¥4,980)
Exchange Rate: 1 USD = ¥152.91

FY2025 December Financial Results Presentation Materials

For the fiscal year ended December 2025, consolidated net sales were 86.65 billion yen (YoY +6.7%), operating income was 6.18 billion yen (YoY +35.5%), and net income attributable to owners of parent was 3.81 billion yen (YoY -12.5%).

Importance:
Page Updated: February 16, 2026
IR Disclosure Date: February 16, 2026

Key Figures

  • Consolidated Net Sales: 86.65 billion yen (YoY +6.7%)
  • Consolidated Operating Income: 6.18 billion yen (YoY +35.5%)
  • Net Income Attributable to Owners of Parent: 3.81 billion yen (YoY -12.5%)

AI要約

Overview of FY2025 December Financial Results

For the fiscal year ended December 2025, consolidated net sales increased by 6.7% year-over-year to 86.65 billion yen, and operating income rose by 35.5% year-over-year to 6.18 billion yen. However, net income attributable to owners of parent decreased by 12.5% year-over-year to 3.81 billion yen. Capital expenditures amounted to 7.11 billion yen, representing a 32.4% year-over-year increase, reflecting continued proactive investments. By segment, the synthetic resin business, new materials business, building materials business, and other related businesses each recorded either higher revenue and profit or higher revenue and lower profit.

Business Segment Trends and Outlook

The synthetic resin business posted increased profit despite a decline in demand for packaging films, thanks to price revisions and cost reductions. The new materials business recorded substantial profit growth due to increased orders for optical films for large LCD TVs and stable operation of the new plant. The building materials business experienced profit decline caused by recording inventory valuation losses, despite steady demand for remodeling. The other related businesses saw profit decline due to increased system update costs for dispensing pharmacies, although inbound demand and sales within the group increased. The earnings forecast for FY2026 December is currently unavailable.

Consolidated Net Sales Trend

Consolidated Operating Income Trend

Consolidated Capital Expenditure Trend

Quarterly Consolidated Net Sales and Operating Income Trend

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.